Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04151472 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT04151472 · ClinicalTrials.gov record · last posted 2025-05-15

Idebenone for the Preventive Treatment of Migraine

StatusRecruiting
PhasePhase 3
Started2021-12-08
View on ClinicalTrials.gov ↗
Record status
This record was last updated May 15, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
from the ClinicalTrials.gov record
Idebenone improves energy metabolism similarly to Coenzyme Q10, which is effective in migraine prophylaxis. The investigators compare idebenone (90 mg/day, 270 mg/day) and placebo in 180 migraine patients in a double-blind, randomized, placebo-controlled, multicenter trial to study whether Idebenone is superior to placebo in the prevention of episodic migraine with or without aura.

Protocol amendment history 1 change detected by DataLookout

2026-08-09
Sponsor changed: Second Affiliated Hospital, School of Medicine, Zhejiang University → Second Affiliated Hospital, Zhejiang University, School of Medicine
WasSecond Affiliated Hospital, School of Medicine, Zhejiang University
NowSecond Affiliated Hospital, Zhejiang University, School of Medicine
Trial Details
NCT Number NCT04151472
Lead Sponsor Second Affiliated Hospital, School of Medicine, Zhejiang University
Conditions Migraine Disorders, Headache Disorders
Enrollment 180 participants
Start Date 2021-12-08
Primary Completion 2025-12-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-05-15